Menu Search
Equities

CME Group Inc

CME:NSQ

CME Group Inc

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)214.76
  • Today's Change-1.54 / -0.71%
  • Shares traded2.89m
  • 1 Year change+4.01%
  • Beta0.5598
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy4
Outperform4
Hold5
Sell3
Strong Sell0

Share price forecast in USD

The 12 analysts offering 12 month price targets for CME Group Inc have a median target of 218.00, with a high estimate of 250.00 and a low estimate of 177.00. The median estimate represents a 1.51% increase from the last price of 214.76.
High16.4%250.00
Med1.5%218.00
Low-17.6%177.00

Dividends in USD

In 2023, CME Group Inc reported a dividend of 4.40 USD, which represents a 10.00% increase over last year. The 9 analysts covering the company expect dividends of 9.72 USD for the upcoming fiscal year, an increase of 120.86%.
Div growth (TTM)10.00%
More ▼

Earnings history & estimates in USD

On Jul 24, 2024, CME Group Inc reported 2nd quarter 2024 earnings of 2.56 per share. This result was in line with the consensus of the 13 analysts following the company and exceeded last year's 2nd quarter results by 11.30%.
The next earnings announcement is expected on Oct 23, 2024.
Average growth rate+2.76%
CME Group Inc reported annual 2023 earnings of 9.34 per share on Feb 14, 2024.
Average growth rate+8.69%
More ▼

Revenue history & estimates in USD

CME Group Inc. had 2nd quarter 2024 revenues of 1.53bn. This missed the 1.53bn consensus estimate of the 12 analysts following the company. This was 6.31% above the prior year's 2nd quarter results.
Average growth rate+3.08%
CME Group Inc. had revenues for the full year 2023 of 5.58bn. This was 11.15% above the prior year's results.
Average growth rate+3.63%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.